Extremely Low Gestatonal Age Infants' Paracetamol Study

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2018

Primary Completion Date

November 3, 2023

Study Completion Date

March 1, 2024

Conditions

Prematurity; ExtremeLow Birthweight, Extremely (999 Grams or Less)

Interventions

DRUG

Paracetamol 10mg/mL infusion solution

Intravenous paracetamol solution for infusion

OTHER

Placebo

Half physiological saline solution as the non-active placebo solution

Trial Locations (1)

Department of Pediatrics, Oulu University Hospital, Oulu

All Listed Sponsors

lead

Outi Aikio

OTHER

NCT03641209 - Extremely Low Gestatonal Age Infants' Paracetamol Study | Biotech Hunter | Biotech Hunter